Genomic Imaging
for Precision Medicine

Better tests.
Better treatments.
Better outcomes.

3D Signatures Inc. is a novel personalized medicine company with proprietary software that can analyze a patient’s chromosomal arrangement – or signature – through a simple non-invasive blood test or tissue sample, measuring disease stage and genomic stability, as well as drug efficacy and potential side effects. The technology is designed to predict the course of disease and to customize treatment for the individual patient.
Better Outcomes

We are dedicated to improving treatment outcomes by providing precision diagnostic and prognostic tools.

Our pipeline

Our development pipeline is focused on cancers and neurological disorders.

Product Overview

Our novel 3D technology enables clinicians to develop personalized treatment programs for patients.

Enabling Truly Personalized Medicine

Based on Dr. Sabine Mai’s groundbreaking research, 3D Signatures is the first and only company to understand and quantify normal versus disease state telomere arrangement, turning this into usable, predictable, reliable, and highly valuable information that can improve patient outcomes. This disruptive technology platform is fundamentally different from conventional diagnostic methods and could represent an entirely new class of biomarkers for diseases like cancer and Alzheimer’s.

$ 0 M+
in R&D
Cancers, Alzheimer's Studied
Clinical studies
0 +
Peer-reviewed papers